Lifevantage - Public Comps and Valuation Multiples

Lifevantage Overview

About Lifevantage

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.

Founded

1988

HQ

Employees

238

Website

lifevantage.com

Sectors

Food & Beverages

Financials

LTM Revenue $229M

LTM EBITDA $22.2M

EV

$133M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Lifevantage Financials

As of August 2025, Lifevantage reported last 12-month revenue of $229M and EBITDA of $22.2M.

In the same period, Lifevantage generated $185M in LTM gross profit and $10.4M in net income.

See Lifevantage valuation multiples based on analyst estimates

Lifevantage P&L

In the most recent fiscal year, Lifevantage reported revenue of $229M and EBITDA of $15.4M.

Lifevantage expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Lifevantage valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$229M	XXX	$229M	XXX	XXX	XXX
Gross Profit	$185M	XXX	$184M	XXX	XXX	XXX
Gross Margin	80%	XXX	80%	XXX	XXX	XXX
EBITDA	$22.2M	XXX	$15.4M	XXX	XXX	XXX
EBITDA Margin	10%	XXX	7%	XXX	XXX	XXX
EBIT	$13.4M	XXX	$12.2M	XXX	XXX	XXX
EBIT Margin	6%	XXX	5%	XXX	XXX	XXX
Net Profit	$10.4M	XXX	$9.8M	XXX	XXX	XXX
Net Margin	5%	XXX	4%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Lifevantage including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $229M. EBITDA for the last twelve months was $22.2M. In the most recent fiscal year, Lifevantage achieved $229M in revenue and $15.4M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$229M	Analyst estimates available to subscribers	$229M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$185M	Analyst estimates available to subscribers	$184M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	80.5% gross margin	Analyst estimates available to subscribers	80.4% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$22.2M	Analyst estimates available to subscribers	$15.4M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	9.7% EBITDA margin	Analyst estimates available to subscribers	6.7% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$13.4M	Analyst estimates available to subscribers	$12.2M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	5.9% EBIT margin	Analyst estimates available to subscribers	5.3% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$10.4M	Analyst estimates available to subscribers	$9.8M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	4.5% net profit margin	Analyst estimates available to subscribers	4.3% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Lifevantage

This financial data table provides comprehensive performance metrics for Lifevantage, a company based in United States of America. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Lifevantage generated $229M in revenue over the last twelve months.
The company achieved $22.2M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $185M.
Net income over the last twelve months reached $10.4M.

Fiscal Year Performance

In the most recent fiscal year, Lifevantage reported $229M in total revenue.
Fiscal year EBITDA was $15.4M.
The company maintained a gross profit margin of 80.4% in the most recent fiscal year.
EBITDA margin for the fiscal year was 6.7%.
Net profit margin reached 4.3% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Lifevantage. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Lifevantage Stock Performance

Lifevantage has current market cap of $141M, and EV of $133M.

Market Cap Evolution

Lifevantage Stock Data

As of September 12, 2025, Lifevantage's stock price is $11.

See Lifevantage trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$133M	$141M	XXX	XXX	XXX	XXX	$0.86

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Lifevantage Valuation Multiples

Lifevantage's trades at 0.6x EV/Revenue multiple, and 11.4x EV/EBITDA.

See valuation multiples for Lifevantage and 15K+ public comps

Lifevantage Financial Valuation Multiples

As of September 12, 2025, Lifevantage has market cap of $141M and EV of $133M.

Equity research analysts estimate Lifevantage's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Lifevantage has a P/E ratio of 13.6x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$141M	XXX	$141M	XXX	XXX	XXX
EV (current)	$133M	XXX	$133M	XXX	XXX	XXX
EV/Revenue	0.6x	XXX	0.6x	XXX	XXX	XXX
EV/EBITDA	6.0x	XXX	11.4x	XXX	XXX	XXX
EV/EBIT	9.9x	XXX	16.1x	XXX	XXX	XXX
EV/Gross Profit	0.7x	XXX	n/a	XXX	XXX	XXX
P/E	13.6x	XXX	22.2x	XXX	XXX	XXX
EV/FCF	27.1x	XXX	13.0x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Lifevantage Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Lifevantage Margins & Growth Rates

Lifevantage's last 12 month revenue growth is 2%

Lifevantage's revenue per employee in the last FY averaged $1.0M, while opex per employee averaged $0.7M for the same period.

Lifevantage's rule of 40 is 8% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Lifevantage's rule of X is 15% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Lifevantage and other 15K+ public comps

Lifevantage Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	2%	XXX	5%	XXX	XXX	XXX
EBITDA Margin	10%	XXX	5%	XXX	XXX	XXX
EBITDA Growth	3%	XXX	42%	XXX	XXX	XXX
Rule of 40	8%	XXX	8%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	15%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$1.0M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.7M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	75%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial